Objectives: Fosfomycin activity in Escherichia coli depends on several genes of unknown importance for fosfomycin resistance. The objective was to characterize the role of uhpT, glpT, cyaA and ptsI genes in fosfomycin resistance in E. coli.
Introduction
The continuous increase of antibiotic resistance reported worldwide in Enterobacteriaceae, together with the lack of new active compounds, has made it necessary to rescue old antibiotics as an alternative strategy. 1 Fosfomycin, currently used for uncomplicated urinary tract infections, 2 has attracted renewed interest due to its proven efficacy in the management of difficult-to-treat infections caused by multidrug-resistant Enterobacteriaceae. 3 Fosfomycin is able to inhibit the enzyme UDP-N-acetylglucosamine enolpyruvyl transferase (MurA), which catalyses the initial step in peptidoglycan biosynthesis. The way in which fosfomycin reaches the cytosol and blocks MurA activity is under the control of complex metabolic networks. Two membrane transporters, belonging to the major facilitator superfamily, have been described in fosfomycin intake. 4 UhpT is a hexose phosphate transporter and
GlpT is the major Escherichia coli uptake system for glycerol-3-phosphate. In both cases, transport occurs with the simultaneous counterflow of inorganic phosphate from the bacteria. 5 UhpT expression is mediated by a two-component regulatory system (UhpBC), together with the regulon-specific activator (UhpA), and by catabolite repression, through the action of the cyclic AMP (cAMP)-cAMP receptor protein complex (CRP, also known as CAP), which regulates the transcription of .100 catabolic genes. 6, 7 Expression of the glpT gene is under the control of the repressor GlpR and is positively regulated by cAMP-CRP and FNR (the primary transcriptional regulator that mediates the transition from aerobic to anaerobic growth). 8 The transcription activator cAMP-CRP also plays an important role in the regulatory phenomenon known as carbon catabolite repression, by which the expression of functions for the use of secondary carbon sources and the activities of the corresponding enzymes are reduced in the presence of a preferred carbon source. 9 Carbon catabolite repression in E. coli is regulated by the central processing unit, the glucose-specific phosphotransferase enzyme IIA component of the glucose transporter (EIIAGlc). When phosphorylated, EIIAGlc binds and activates adenylate cyclase (cyaA), which leads to cAMP synthesis. High cAMP concentrations trigger the formation of cAMP-CRP complexes, which bind and activate the promoters of catabolic genes. EIIAGlc is phosphorylated by phosphoenolpyruvate in a reaction requiring PtsH and PtsI.
The complexity of regulation affecting fosfomycin uptake and activity reflects the potential role of many genes in the susceptibility to fosfomycin. Excluding plasmid-mediated fosfomycin resistance due to the presence of fos genes, different studies have related chromosomal mutations in murA, uhpT, uhpA, glpT, cyaA and ptsI genes to fosfomycin resistance in clinical isolates. [10] [11] [12] [13] However, the contribution made by each chromosomal mutation to global fosfomycin resistance is not well understood because mutations in these genes are often present in combination. In addition, fosfomycin-resistant isolates have been described without mutations in the genes. [10] [11] [12] [13] A better understanding of the development of fosfomycin resistance would help support the rational design of fosfomycin susceptibility breakpoints based on the ability of some mutants susceptible to fosfomycin to reach high levels of resistance.
In the present study, the contribution of genes implicated in the intracellular transport of fosfomycin (uhpT, glpT, cyaA and ptsI) was evaluated using single-and double-gene deletion mutants in an isogenic collection of E. coli. The results provided insights into the development of fosfomycin resistance in E. coli.
Materials and methods

Bacterial strains
E. coli (BW25133) single-gene deletion mutants (DglpT, DuhpT, DcyaA and DptsI) associated with fosfomycin resistance were selected from the KEIO collection.
14 The kanamycin resistance determinant was subsequently removed from the chromosome, following the protocol of Cherepanov and Wackernagel. 15 Briefly, the pCP20 plasmid was electroporated into each KEIO clone. Transformants were selected on LB agar plates containing chloramphenicol (30 mg/L; Sigma-Aldrich, Madrid, Spain) and incubated at 30 C for 20-24 h. Then, five colonies were grown on drug-free LB agar plates and incubated at 43 C for 18 h to eliminate the pCP20 plasmid. Double-gene deletion mutants (DglpT-uhpT, DglpT-cyaA, DglpT-ptsI, DuhpT-cyaA, DuhpT-ptsI and DptsI-cyaA) were generated by phage P1vir transduction [Coli Genetic Stock Center (CGSC), Yale University] from the previously selected strains, as described. 16 For each single-and double-gene deletion mutant, the murA, glpT, uhpA, uhpB, uhpC, uhpT, ptsI, crp or cyaA genes were PCR amplified using specific primers (Table 1 ) and sequenced to confirm gene deletion and the absence of other possible mutations related to fosfomycin resistance.
Susceptibility tests
Susceptibility testing for fosfomycin was performed in triplicate by the agar dilution method, following CLSI guidelines. Briefly, a replicator pin 1 mm in diameter transferred an inoculum of 10 4 cfu/spot of bacterial suspension to the agar surface. Mueller-Hinton II agar (MHA) plates (Becton-Dickinson, Sparks, MD, USA) containing 25 mg/L glucose-6-phosphate (G6P) (SigmaAldrich) and fosfomycin (Sigma-Aldrich) at concentrations ranging from 0.25 to 1024 mg/L were prepared. The plates were allowed to dry and then incubated in ambient air for 16-20 h at 35 C. The MIC recorded was the lowest concentration of antimicrobial agent that completely inhibited growth, disregarding a single colony or a faint haze caused by the inoculum. E. coli ATCC 25922 was used as the control strain. Testing of susceptibility to 
Fosfomycin mutant frequency
Mutant frequencies were assessed for the four single and six double mutants. WT strain E. coli BW25113 was included as a control. The mutant frequency for fosfomycin resistance was determined as follows. An overnight culture of each strain (10 9 cfu/mL) was diluted 1:10 7 to avoid the presence of mutants in the initial culture. An initial inoculum of 10 2 cfu/mL was then incubated overnight in Mueller-Hinton broth (MHB) and subsequently placed on drug-free plates (to calculate the total bacterial concentration) and on MHA II-G6P plates containing fosfomycin (to estimate the subpopulation able to grow at this antimicrobial concentration). Mutants were isolated from MHA II-G6P plates supplemented with fosfomycin at concentrations of 64 and 256 mg/L for single-gene deletions and 256 mg/L for double-gene deletions. Plates were incubated for 48 h at 37 C. The experiments were performed in quintuplicate. Fosfomycin mutant frequencies of each single mutant and its corresponding double mutant were compared using ANOVA and the post hoc Tukey and Dunnett tests. Statistical analyses were performed using SPSS 22.0 (IBM, Armonk NY, USA). P , 0.05 was considered significant.
In vitro fosfomycin activity by time-kill curves
In vitro fosfomycin activity was assessed by time-kill curves as follows. A starting bacterial inoculum of 10 6 cfu/mL was used and fosfomycin concentrations of 64 mg/L (the highest susceptible concentration according to current CLSI breakpoints) and 307 mg/L (mean maximum plasma concentration in humans observed at steady-state after a dose of 8 g fosfomycin every 8 h) were tested. 17 Experiments were performed in MHB II-G6P (20 mL). Bacterial growth was quantified at 0, 4, 24 and 48 h after incubation, with shaking at 37 C. Samples were properly diluted in 100-fold dilutions and plated on to MHA II plates to estimate viable numbers.
Fosfomycin-resistant mutants from time-kill curves
When bacterial regrowth was observed after 48 h on the time-kill curves, up to five colonies were selected to assess the MIC of fosfomycin and genotype changes. The isolated mutants were serially passaged five times on fosfomycin-free plates to assess the stability of the phenotype. Fosfomycin MIC was determined as previously stated. Owing to the stability of the resistance phenotype, mutants recovered from each condition were sequenced looking for additional mutations in murA, glpT, uhpA, uhpB, uhpC, uhpT, ptsI, crp and cyaA genes.
Results
Contribution of single and double mutants to fosfomycin resistance
The fosfomycin MICs for the isogenic collection are shown in Table 2 . No increase in MIC was observed for the DglpT and DptsI strains with respect to the WT strain (2 mg/L). Of the single-gene deletion variants/mutants, only loss of the cyaA or uhpT genes caused a 4-and 32-fold increase, respectively, in the fosfomycin MIC. All the single-gene deletion mutants were susceptible to fosfomycin. The combined mutations of DglpT-cyaA, DglpT-ptsI and DuhpT-ptsI showed no synergistic effect on fosfomycin resistance. However, DptsI-cyaA, DglpT-uhpT and DuhpT-cyaA led to a 4-8-fold increase in the MIC of fosfomycin relative to the highest MIC of the single-gene mutant alone. In spite of carrying two deleted genes, DglpT-cyaA, DglpT-ptsI, DuhpT-ptsI and DptsI-cyaA were susceptible, while DglpT-uhpT and DuhpT-cyaA were resistant to fosfomycin according to CLSI guidelines.
Variations in fosfomycin mutant frequency
Fosfomycin mutant frequencies for the isogenic collection at 64 and 256 mg/L are shown in Table 2 . No mutants were recovered from the BW25113 strain at any of the fosfomycin concentrations tested. Inactivating mutations in the glpT, cyaA and ptsI genes led to the selection of mutants at 64 mg/L. However, neither the DglpT nor DptsI strains was able to produce colonies at 256 mg/L, in contrast to DcyaA and DuhpT. The DuhpT strain, with an MIC of 64 mg/L, showed a mutation frequency of 2.9 % 10 #5 using the MIC for selection. This result would appear to indicate that, in this mutant, an MIC of 64 mg/L could be caused by part of the bacterial population. Conversely, a mutation frequency close to 1, observed Fosfomycin resistance in E. coli JAC in DglpT-uhpT and DuhpT-cyaA strains, with MICs of 256 and 512 mg/L respectively, indicates that the majority of the bacterial population share this susceptibility.
It is important to note the increase in the fosfomycin mutant frequency in the double mutant DglpT-ptsI (9.4 % 10
#7
) with respect to each single mutant (,10
#9
). The other double mutants (DglpT-cyaA, DuhpT-ptsI) did not significantly increase the mutant frequency relative to the highest frequency observed in each single mutant.
In vitro fosfomycin activity in time-kill curves
The time-kill curves are represented in Figure 1 . Fosfomycin showed rapid bactericidal activity against BW25113 at both Figure 1 . Time-kill curves for E. coli single-gene deletion mutants (DglpT, DuhpT, DcyaA and DptsI) and double-gene deletion mutants (DglpT-uhpT, DglpT-cyaA, DglpT-ptsI, DuhpT-cyaA, DuhpT-ptsI and DptsI-cyaA), using 64 and 307 mg/L fosfomycin.
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concentrations tested. In our isogenic collection, a 2-4 log 10 cfu/mL reduction in colony count was observed within the first 4 h with both antibiotic concentrations, with the exception of the DptsI-cyaA, DuhpT-ptsI, DglpT-uhpT and DuhpT-cyaA mutants with MICs of 32, 64, 256 and 512 mg/L, respectively. With the exception of WT E. coli BW25113, all strains evaluated using 64 mg/L fosfomycin showed regrowth, even though their MICs were below this concentration after 24 h incubation. Similar results were achieved using 307 mg/L fosfomycin, where all the mutants regrew, except for DglpT and DptsI mutants, the two with the lowest MICs (2 mg/L). It is noteworthy that the DuhpT mutant, despite having an MIC of 64 mg/L, showed a high bacterial reduction using 1% MIC of fosfomycin. Overall, the results fit well with those obtained in the fosfomycin mutant frequency experiments. Those strains with a mutant frequency close to or .10 #6 for any fosfomycin concentration showed bacterial regrowth during the time-kill experiments.
Mutant analysis
Five colonies of each mutant recovered at the 24 h time point were selected. After five serial passages on fosfomycin-free plates, the stability of the mutants was confirmed. All recovered strains showed fosfomycin MICs of .1024 mg/L, regardless of the fosfomycin concentration at which they were selected or their initial susceptibility.
The characteristics of the fosfomycin-resistant strains are described in Table 3 . Most of the mutations lay in the uhp operon, except when uhpT had previously been deleted. In these cases, mutations in glpT or crp were observed. No additional mutations were found in DglpT-uhpT or DuhpT-cyaA.
Discussion
Fosfomycin is a broad-spectrum bactericidal antibiotic, which requires intracellular transport to block the first step of peptidoglycan synthesis. Fosfomycin resistance has been associated with plasmid-encoded inactivating enzymes or chromosomal mutations in genes related to the fosfomycin target (murA) or to fosfomycin intake (glpT, uhpA, uhpT, cyaA or ptsI). [10] [11] [12] [13] These mutations often appear in combination and the contribution of each gene to the fosfomycin resistance remains unknown. In the present study, the importance of the main chromosomal genes related to fosfomycin susceptibility was analysed. The results presented here show that the presence of these chromosomal mutations alone, or even in selected combinations, increases the MIC of fosfomycin, but does not confer resistance according to current susceptibility breakpoints (i.e. MIC ,256 mg/L). 18 In our conditions, this means that fosfomycin resistance is not caused by a single-step mutation, but that a sequential process of mutations is required. This is important because the addition of G6P to the medium used for susceptibility testing may mask mutants unrelated to the hexose phosphate transporter (UhpT) and so yield low fosfomycin MIC values. In such cases, the presence of these single mutations may yield a fosfomycin-susceptible phenotype, but will facilitate the selection of highly resistant subpopulations when additional mutations appear; in this regard, this effect may be caused by deletions in the glpT or ptsI genes. WT E. coli BW25113 and the DglpT and DptsI strains had the same fosfomycin MIC, although the presence of these single mutations with no apparent effect on the MIC led to changes in mutant frequency from .10 #9 to 1.3 % 10 #5 (DglpT) or 9.7 % 10 #7 (DptsI). As a result of this effect, BW25113, DglpT and DptsI strains behaved differently in the presence of fosfomycin. Fosfomycin resistance in E. coli
JAC
Bacterial regrowth was observed in the time-kill experiments performed with DglpT and DptsI strains when fosfomycin concentrations were 32 times (64 mg/L) higher than the MIC value (2 mg/L). This result was consistent with the mutant frequency observed for this fosfomycin concentration and an initial bacterial concentration of 10 6 cfu/mL (in 20 mL volume). Thus, bacterial subpopulations with increased MICs were present at the beginning of the assay and then selected for by the presence of fosfomycin. In the time-kill experiments, the absence of regrowth in higher concentrations (307 mg/L) occurred because the higher concentration of fosfomycin prevented the selection of highly resistant mutants, correlating also with the mutant frequency (.10
#9
) observed at concentrations of 256 mg/L.
The other single mutants, DuhpT (MIC of 64 mg/L) and DcyaA (MIC of 8 mg/L), both susceptible, behaved similarly, with regrowth at 64 and 307 mg/L fosfomycin, due to the appearance of mutations in the cAMP-CRP complex and uhp operon, respectively.
It should be noted that no additional mutations were found in DglpT-uhpT or DuhpT-cyaA. Taking into account their high fosfomycin MIC, this could indicate the existence of additional mechanisms in the cell that could lead to extremely high levels of resistance.
A limitation of the present study could be the use of a bacterial collection made up of gene deletions instead of point mutations. Using this strategy, comparison of DmurA mutants could not be performed as the murA gene is essential for cell viability and could not be deleted.
14 murA point mutations are not the most common mutation found in fosfomycin-resistant isolates. [11] [12] [13] The high frequency of mutations in the uhp operon could also be explained by the mutant selection conditions. The use of G6P with fosfomycin preferably selects mutants in the hexose phosphate transport system rather than others.
The use of fixed concentrations in the time-kill assays may not reflect the in vivo response of fosfomycin. Nevertheless, consistent with the present results, the importance of pre-existing subpopulations involved in fosfomycin therapeutic failure has been observed previously, both in our work and by other authors using in vitro dynamic infection models. 19, 20 Thus, it is important to select a rational starting dose for fosfomycin aimed at eliminating subpopulations with increased MICs that are sometimes not detected in susceptibility tests but are able to acquire additional mutations and become highly resistant.
Finally, as the number of mutants and genes analysed was limited, and taking into account the complexity of the regulatory networks affecting the metabolic pathways involved, we were unable to exclude the role of other genes that affected the susceptibility to fosfomycin.
In conclusion, the fosfomycin MIC may not be a good predictor of efficacy. Highly resistant mutants may appear, depending on other pre-existing mutations that have no impact on the MIC obtained with commonly used susceptibility testing methods.
These findings provide information that contributes to a better understanding of the impact of different mutations on fosfomycin activity and point to the need for a method to evaluate fosfomycin activity in vitro that is able to predict the appearance of resistant mutants as they occur during fosfomycin therapy.
